In this study, we also demonstrate that both hemi- and homozygous PTEN loss is a highly significant prognostic marker for poor clinical outcome in prostate cancer.
← all excerpts
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.
1
—
—